Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline. - Wikidata - wikimedia - TriplyDB

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

http://www.wikidata.org/entity/Q33675495

about

Approach to GERD.The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital.The hidden curriculum and continuing professional development for family physicians.Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.Is There a Reason for the Proton Pump Inhibitor? An Assessment of Prescribing for Residential Care Patients in British Columbia Q58557264 Deprescribing Proton Pump Inhibitors Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis

P2860

Q42345373-9BD613FF-6D58-48C5-B59D-08C091435E03 Q49988267-B63019F7-754F-430C-8E4E-F966C5F88FC7 Q54949819-B3541EFD-675A-48CE-AA82-5FEEF19D6905 Q55071130-A9BF4DF6-135F-41E9-A015-11B015F93284 Q58557258-5E315799-3DCE-4B7E-B6BF-187234BD3E38 Q58557264-3393DB0A-619B-47A3-9688-E327B710DB0F Q58557278-53D3DD40-ACD2-4729-A840-2E52F03B6D5B Q58780145-ED14BF3A-B436-42DC-BEA9-CA2822F9C848

P2860

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

http://www.wikidata.org/entity/Q33675495

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

@ast

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

@en

type

label

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

@ast

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

@en

prefLabel

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

@ast

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

@en

P1433

Q33675495-91DB4D73-A641-4F73-8350-A6661BA5AD45

P1476

Q33675495-85F3AE10-53C6-4D72-80EA-9639DF449BB9

P2093

Q33675495-2B07B20E-17F1-4060-A34D-A083AAED981E

Q33675495-4049376F-A507-4B66-896B-3BE69340A297

Q33675495-559C8D6B-11D3-48C6-B02E-2C72DF99BAB8

Q33675495-7BD6A33C-9FE5-41E7-B0DF-73A58DDBB444

Q33675495-88A41EA5-45C4-4E96-9664-CEF8E3994586

Q33675495-8984BFEB-78C3-43AB-A246-6AA59DF417DD

Q33675495-8E9B22F2-A129-4A6D-B24C-03D2E34FDCD0

Q33675495-D9A032AE-A9CB-4AC9-9921-06CA942C6B53

Q33675495-E9EEC675-16A9-436B-B9C2-4E4E1D6540A8

P2860

Q33675495-05126A7A-9776-46E5-A51F-41C4A85DA1E7

Q33675495-09AA2774-CD64-43C3-80EE-70ED8088C206

Q33675495-104C1B78-B150-4EC7-8459-3E40AE79CBA6

Q33675495-16DF535F-245A-42F4-93C1-E5A7746AEA29

Q33675495-1AA9C87A-BB78-47C0-9F73-411B8CAD5BFD

Q33675495-20B96A79-DF2F-47D1-97E9-12019FB5A6AD

Q33675495-20CA935C-3A63-454B-89BF-7F82811B8259

Q33675495-3383371E-C488-41B3-B9AD-373A88A45296

Q33675495-366B6F1A-24FF-4C6D-896F-7A75A9F7FE9F

Q33675495-39D65F70-B37D-4255-AA73-E1090BAA17C3

P304

Q33675495-2A5B92D6-4CF6-4C5B-9C28-E44CA73F4A57

P31

Q33675495-4E87EBAE-3B83-4A23-B45F-6F30DB6A845D

P407

Q33675495-9289A8E9-14AE-4FFF-962B-0D95B4C3F04A

P433

Q33675495-69CCF771-A0CF-45C5-AF4D-C4FCFBFABA55

P478

Q33675495-A5E4CF34-D2BE-4A86-8954-F7D9618AF53B

P50

Q33675495-807869A7-DCA9-407B-B693-CEBC808D5D34

P577

Q33675495-78E20268-3AF2-47A5-9453-A1E5307508E0

P698

Q33675495-BEB3BC03-46D5-47A1-8279-5813B50BDAF4

P932

Q33675495-5BB208B0-A872-437A-95A1-3E91151ABBAC

P1433

Canadian Family Physician

P1476

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

@en

P2093

Barbara Farrell

http://www.w3.org/2001/XMLSchema#string

Carlos Rojas-Fernandez

http://www.w3.org/2001/XMLSchema#string

Farah Joy Rashid

http://www.w3.org/2001/XMLSchema#string

Kate Walsh

http://www.w3.org/2001/XMLSchema#string

Kevin Pottie

http://www.w3.org/2001/XMLSchema#string

Lisa Pizzola

http://www.w3.org/2001/XMLSchema#string

Taline Boghossian

http://www.w3.org/2001/XMLSchema#string

Vivian Welch

http://www.w3.org/2001/XMLSchema#string

Wade Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease

Overutilization of proton-pump inhibitors: what the clinician needs to know

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency

What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

Guidelines for prevention of NSAID-related ulcer complications.

Qualitative insights into general practitioners views on polypharmacy.

Concordance between use of proton pump inhibitors and prescribing guidelines.

Overuse of acid-suppressive therapy in hospitalized patients.

P304

354-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28500192

http://www.w3.org/2001/XMLSchema#string

P932

5429051

http://www.w3.org/2001/XMLSchema#string